Compare AVNS & CION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AVNS | CION |
|---|---|---|
| Founded | 2014 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 521.7M | 464.0M |
| IPO Year | 2014 | 2011 |
| Metric | AVNS | CION |
|---|---|---|
| Price | $13.71 | $6.55 |
| Analyst Decision | | Sell |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | 556.2K | ★ 565.3K |
| Earning Date | 01-01-0001 | 05-12-2026 |
| Dividend Yield | N/A | ★ 17.34% |
| EPS Growth | ★ 81.59 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $701,200,000.00 | N/A |
| Revenue This Year | $3.28 | N/A |
| Revenue Next Year | $4.23 | N/A |
| P/E Ratio | ★ N/A | $17.55 |
| Revenue Growth | ★ 1.95 | N/A |
| 52 Week Low | $9.30 | $6.92 |
| 52 Week High | $15.68 | $11.24 |
| Indicator | AVNS | CION |
|---|---|---|
| Relative Strength Index (RSI) | 49.96 | 11.69 |
| Support Level | $13.45 | N/A |
| Resistance Level | $15.68 | $10.17 |
| Average True Range (ATR) | 0.58 | 0.27 |
| MACD | -0.15 | -0.12 |
| Stochastic Oscillator | 44.06 | 0.76 |
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.
CION Invt Corp is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company. The Company's portfolio is comprised of investments in senior secured debt, including first lien loans, second lien loans, and unitranche loans, and, to a lesser extent, collateralized securities, structured products and other similar securities, unsecured debt, and equity, of private and thinly-traded U.S. middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation for investors.